The STAT3 dependence of this reprograming efficiency was confirmed by its improvement following overexpression of functional wild-type STAT3 in AD-HIES fibroblasts (Fig. 2) and by recapitulating reprogramming deficiency by knocking-down STAT3 in normal skin fibroblasts (Fig. 3). This evidence concerns the gene STAT3 and Alzheimer disease.